Author

Jean Français Baurain

Observed names: J.‐F. Baurain, Jean Baurain, Jean F Baurain, Jean Francais Baurain, Jean-Francais Baurain

Institutions: Cliniques Universitaires Saint-Luc, UCLouvain

Observed institutions: Cliniques Universitaires Saint-Luc, Universitair Ziekenhuis Leuven, de Duve Institute, UCLouvain

OpenAlex ID: A5103767747

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

2017 · Martin J van den Bent, Brigitta Baumert, et al. · The Lancet · 394

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

2021 · Martin J van den Bent, C Mircea S Tesileanu, et al. · The Lancet Oncology · 330

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations

2021 · C. Mircea S. Tesileanu, Wies R. Vallentgoed, et al. · Acta Neuropathologica · 61

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma

2021 · C Mircea S Tesileanu, Martin J van den Bent, et al. · Neuro-Oncology · 60

ACTR-11. SECOND INTERIM AND 1ST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CODELETION

2019 · Martin van den Bent, Sara Erridge, et al. · Neuro-Oncology · 5

Correction of HLA‐Cw*0501 and identification of HLA‐Cw*0711

1999 · J.‐F. Baurain, P.G. Coulie · Tissue Antigens · 4

CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA

2020 · C Mircea S Tesileanu, Pim French, et al. · Neuro-Oncology · 1

PATH-11. PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON

2020 · C Mircea S Tesileanu, Martin van den Bent, et al. · Neuro-Oncology · 1

DNA methylation and survival differences associated with the type of IDH mutation in 1p/19q non-codeleted astrocytomas

2020 · C Mircea S Tesileanu, Wies R Vallentgoed, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 9

Citation count: 854

H-index: 5

I10-index: 4